Cargando…
Einsatz von Biosimilars in der Behandlung der rheumatoiden Arthritis: Ein Überblick
Biologics have been an integral part of the treatment of rheumatoid arthritis for approximately 20 years. As patents for pharmaceuticals generally expire after 10 years, in recent years biosimilars have come onto the market. Many studies have shown that they are an equivalent alternative to the refe...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894295/ https://www.ncbi.nlm.nih.gov/pubmed/34825948 http://dx.doi.org/10.1007/s00393-021-01129-6 |